Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance InductionSang-oh Han, Dwight D. Koeberl, Songtao Li et al.|Molecular Therapy — Methods & Clinical Development|2017Cited by 77
Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance InductionSang-oh Han, Dwight D. Koeberl, Giuseppe Ronzitti et al.|Molecular Therapy — Methods & Clinical Development|2019Cited by 6